The higher rate of PIK3CA mutations in advanced TNBC relative to early-stage TNBC is likely due to ER expression loss in relapsed breast cancer that was initially positive for ER, a subtype that harbors a high rate of PIK3CA mutations [19]. This evidence concerns the gene ESR1 and breast carcinoma.